Mirum Pharmaceuticals Inc (MIRM) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Mirum Pharmaceuticals Inc   (NASDAQ: MIRM)
 

Mirum Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2026, Mirum Pharmaceuticals Inc has not recorded any inventories.
Visit Mirum Pharmaceuticals Inc Balance sheet

Within Healthcare sector 112 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 535 in the second quarter 2026, to 1107.

MIRM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Mirum Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?




MIRM Inventory Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 6.1 % 12.33 % 13.83 % 11.09 % 11.24 %
Y / Y Cost of Sales Growth - - 25.14 % 35.55 % 22.74 %
Inventory Turnover Ratio (TTM) - - 3.5 3.37 3.11
MIRM's Total Ranking # 1107 # 535 # 590 # 590 #
Average inventory processing period - - 104 108 117
Seq. Inventory Growth -1.1 % 0.98 % 2.54 % 3.61 % 4.71 %
Seq. Cost of Sales Growth - - -6.72 % 20.92 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 113
Overall Market # 1107

Inventory Turnover Ratio Statistics
High Average Low
4 2.96 0.96
(Mar 31 2025)   (Mar 31 2024)




Financial Statements
Mirum Pharmaceuticals Inc 's Inventories $ 25 Millions Visit MIRM's Balance sheet
Mirum Pharmaceuticals Inc 's Cost of Revenues TTM $ 60 Millions Visit MIRM's Income Statement
What are MIRM's Sales? Visit MIRM's Sales by Segment

Other Inventory Turnover Ratios
Mirum Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MIRM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MIRM's Competitors
Inventory Turnover Ratio for MIRM's Suppliers
Inventory Turnover Ratio for MIRM's Customers

You may also want to know
MIRM's Sales Growth Rates MIRM's Pe Price to earnings ratio MIRM's Receivables Turnover Ratio MIRM's Stock Quote
MIRM's Net Income Growth Rates MIRM's Ps Price to Sales ratio MIRM's Sales per Employee MIRM's Asset Turnover Ratio
MIRM's Net Margin MIRM's Pb Price to Book ratio MIRM's Financial Strength Ratios MIRM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions

Date modified: 2026-11-04T15:20:59+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.